JohnDCahillMD
Infectious Disease • New York, NYAssistant Clinical Professor of Medicine, Columbia P&S
Dr. Cahill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2109 Broadway
New York, NY 10023Phone+1 212-523-8672Fax+1 212-362-2110
Education & Training
Brown UniversityResidency, Emergency Medicine, 1996 - 2000
Icahn School of Medicine at Mount SinaiClass of 1996
Certifications & Licensure
NY State Medical License 2003 - 2025
RI State Medical License 1998 - 2024
CA State Medical License 2017 - 2023
MA State Medical License 2000 - 2023- American Board of Emergency Medicine Emergency Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 93 citationsEfficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-cont...Deepak Cyril D'Souza, Jose Cortes-Briones, Gina Creatura, Grai Bluez, Halle Thurnauer
The Lancet. Psychiatry. 2019-01-01 - 41 citationsThe Psychiatric Consequences of Cannabinoids.Joao P De Aquino, Mohamed Sherif, Rajiv Radhakrishnan, John D. Cahill, Mohini Ranganathan
Clinical Therapeutics. 2018-09-01 - 38 citationsAttenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242.Mohini Ranganathan, N DeMartinis, B Huguenel, F Gaudreault, Martin M. Bednar
Molecular Psychiatry. 2017-02-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
